We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DRUGMAKERS' CONTROL OF VOLUME PRICES KEY TO MEDICARE ASP
DRUGMAKERS' CONTROL OF VOLUME PRICES KEY TO MEDICARE ASP
January 21, 2004
The way drugmakers handle demands for price breaks from large-volume purchasers over the next two years will help determine whether those price concessions will be taken into account when setting reimbursement formulas under the new Medicare Rx law.